NCT00112411已完成2 期
Dose-ranging Double-blind, Placebo-controlled Efficacy Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 18
研究概览
简要总结
This study is designed to evaluate the single-dose effectiveness of two bronchodilator inhalers given at two dose levels in pediatric asthma patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 4 Years 至 11 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Persistent asthma for a minimum of six months duration that has been stable for at least four weeks
- •Predicted FEV1 60-90%
- •Demonstration of 12% airway reversibility
排除标准
- •Continuous requirement for beta-blockers, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants, anticholinergics and/or steroids other than those inhaled;
- •Presence of clinically-significant non-asthmatic acute or chronic disease
研究者
研究点 (18)
Loading locations...
相似试验
已完成
2 期
Study to Evaluate Efficacy and Safety of Inhaled BEA 2180 BR in COPD PatientsPulmonary Disease, Chronic ObstructiveNCT02242279Boehringer Ingelheim37
已完成
3 期
12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPDPulmonary Disease, Chronic ObstructiveNCT00240435Boehringer Ingelheim491
已完成
3 期
12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPDPulmonary Disease, Chronic ObstructiveNCT00239473Boehringer Ingelheim429
已完成
3 期
Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPDEmphysemaChronic Obstructive Pulmonary DiseaseChronic BronchitisNCT00064402Sumitomo Pharma America, Inc.741
已完成
2 期
A Study to Assess the Safety and Tolerability of Once Daily Inhaled Doses of GSK573719 Made With Magnesium Stearate in Subjects With Chronic Obstructive Pulmonary Disease(COPD)for 7 DaysPulmonary Disease, Chronic ObstructiveNCT00732472GlaxoSmithKline37